Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collplant Biotechnologies Ltd CLGN

Healthcare Biotechnology
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I... see more

Recent & Breaking News (NDAQ:CLGN)

CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer

PR Newswire April 12, 2018

CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update

PR Newswire March 21, 2018

CollPlant Joins ReMDO's Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs

PR Newswire February 21, 2018

CollPlant Announces ADS Listing on NASDAQ

PR Newswire January 31, 2018

CollPlant Appoints David Tsur as Chairman of the Board

PR Newswire January 16, 2018

CollPlant Receives Substantial, Repeat Order for Its Biological Ink

PR Newswire November 28, 2017

CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix®FG for Treatment of Acute and Chronic Wounds and Surgical Cuts

PR Newswire November 28, 2017

Vote of Confidence in CollPlant: Completion of Agreement for Immediate Investment of USD 1.1 Million from Ami Sagi, one of the Company's Largest Shareholders

PR Newswire November 13, 2017

Innovation Authority Gives Vote of Confidence: CollPlant Receives Innovation Authority Approval for USD One Million R&D Program with 40% Funding

PR Newswire October 30, 2017

CollPlant Signs Definitive Agreement for $5 Million Private Placement with US Investor

PR Newswire September 11, 2017

CollPlant in Advanced Negotiations for US Private Placement of USD 5.0 million; Agreement Includes Plan for NASDAQ Uplisting

PR Newswire September 5, 2017

CollPlant Files Patent for 3D Bio-Printing of Organs and Tissues

PR Newswire June 12, 2017

CollPlant Provides Operational Update for Q1 2017

PR Newswire May 31, 2017

CollPlant Extends its European Distribution Network With Signing of New Distribution Agreement in Turkey for Vergenix®FG Wound Treatment

PR Newswire May 22, 2017

CollPlant Establishes a Separate Division to Focus on 3D Bio-Printing of Organs and Tissues

PR Newswire May 11, 2017

CollPlant Reports Positive Results From Post-Marketing Surveillance of Vergenix®FG

PR Newswire April 11, 2017

CollPlant Provides Commercial and Operational Update

PR Newswire March 30, 2017

CollPlant Signs Exclusive Distribution Agreement with Arthrex for Vergenix™STR

PR Newswire November 8, 2016

CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy

PR Newswire October 19, 2016

CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy

PR Newswire August 17, 2016